Geode Capital Management, LLC Checkpoint Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.02 - $10.6 $27,171 - $282,373	26,639 Added 3.98%	695,423 $723,000
Q2 2022 Aug 12, 2022	BUY	$0.97 - $1.77 $21,357 - $38,971	22,018 Added 3.4%	668,784 $688,000
Q1 2022 May 13, 2022	BUY	$1.53 - $3.25 $132,807 - $282,106	86,802 Added 15.5%	646,766 $1.14 Million
Q3 2021 Nov 12, 2021	BUY	$2.5 - $3.53 $176,375 - $249,041	70,550 Added 14.42%	559,964 $1.85 Million
Q2 2021 Aug 13, 2021	SELL	$2.36 - $3.2 $729,568 - $989,244	-309,139 Reduced 38.71%	489,414 $1.44 Million
Q1 2021 May 12, 2021	BUY	$2.6 - $4.16 $415,441 - $664,705	159,785 Added 25.01%	798,553 $2.51 Million
Q4 2020 Feb 12, 2021	BUY	$2.19 - $2.96 $126,249 - $170,638	57,648 Added 9.92%	638,768 $1.69 Million
Q3 2020 Nov 13, 2020	BUY	$1.62 - $4.24 $166,536 - $435,872	102,800 Added 21.49%	581,120 $1.56 Million
Q2 2020 Aug 13, 2020	BUY	$1.19 - $2.27 $141,203 - $269,353	118,658 Added 32.99%	478,320 $947,000
Q1 2020 May 14, 2020	BUY	$1.11 - $2.43 $75,991 - $166,360	68,461 Added 23.51%	359,662 $543,000
Q4 2019 Feb 13, 2020	SELL	$1.18 - $2.39 $8,662 - $17,544	-7,341 Reduced 2.46%	291,201 $500,000
Q3 2019 Nov 12, 2019	BUY	$2.15 - $3.36 $2,986 - $4,667	1,389 Added 0.47%	298,542 $743,000
Q2 2019 Aug 14, 2019	BUY	$2.75 - $5.0 $660,533 - $1.2 Million	240,194 Added 421.7%	297,153 $900,000
Q4 2018 Feb 13, 2019	BUY	$1.54 - $3.35 $2,142 - $4,659	1,391 Added 2.5%	56,959 $103,000
Q3 2018 Nov 13, 2018	BUY	$2.46 - $4.72 $136,697 - $262,280	55,568 New	55,568 $198,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $351M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.